Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 43204 (Ingenol Disoxate) in Actinic Keratosis
NCT02120456Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ingenol disoxate in actinic keratosis (AK), sponsored by LEO Pharma. Started May 2014; status: completed.
02
Drugs
ingenol disoxate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02120456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120456.